{"podcast":{"title":"Fitt Insider","slug":"fitt-insider-254580","podcast_index_feed_id":254580,"rss_url":"https://fittinsider.libsyn.com/rss","website_url":"https://insider.fitt.co","image_url":"https://static.libsyn.com/p/assets/4/0/1/0/4010a462593f7c9ad959afa2a1bf1c87/Untitled_design_4.png","author":"Joe Vennare","episode_count":507,"summary":"Fitt Insider is the show where we talk with the entrepreneurs, executives, and investors who are redefining the business of fitness and wellness.","last_synced_at":"2026-09-25T22:20:01.632397+00:00","page_url":"https://stenobird.com/podcast/fitt-insider-254580"},"episode":{"title":"On Stays Premium, Gen Z Bypasses Insurers, FDA Rethinks Psychedelics","slug":"on-stays-premium-gen-z-bypasses-insurers-fda-rethinks-psychedelics","published_at":"2026-09-16T09:30:00+00:00","page_url":"https://stenobird.com/podcast/fitt-insider-254580/on-stays-premium-gen-z-bypasses-insurers-fda-rethinks-psychedelics","show_page_url":"https://stenobird.com/podcast/fitt-insider-254580","url":"https://fittinsider.libsyn.com/on-stays-premium-gen-z-bypasses-insurers-fda-rethinks-psychedelics","audio_url":"https://traffic.libsyn.com/secure/fittinsider/v2_143_-_FI_Daily_Brief.mp3?dest-id=1477619","summary":"September 16, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: On refuses to discount shoes as Q2 sales rise 13.5% to $1B, betting product innovation can support margins that reached 65.4% Accenture survey finds Gen Z and Millennial trust in health insurers fell 10.5%, with 62% already using AI tools to choose a health plan FDA signals more flexibility in psychedelic trial design, opening alternative approaches to comparators, dosing, and approval timelines More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co","meta_description":"September 16, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: On refuses to discount shoes as Q2 sales rise…","key_points":[],"chapters":[],"topics":[],"duration_seconds":234,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/fitt-insider-254580/episodes/on-stays-premium-gen-z-bypasses-insurers-fda-rethinks-psychedelics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/fitt-insider-254580/on-stays-premium-gen-z-bypasses-insurers-fda-rethinks-psychedelics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}